
TECHNOLOGY
10 Dec 2025
AI efforts from Insilico, Nabla Bio, and Takeda speed early metabolic drug design and push firms toward faster data focused R and D

PARTNERSHIPS
9 Dec 2025
Novo Nordisk’s move for Akero boosts momentum in metabolic care; industry players should prepare for faster shifts in liver-disease treatm...

INSIGHTS
8 Dec 2025
Aardvark and Rivus advance early stage metabolic therapies as interest grows beyond GLP 1 drugs and potential new options emerge

RESEARCH
5 Dec 2025
Lilly’s oral orforglipron heats up the race to reshape obesity and diabetes treatment

REGULATORY
4 Dec 2025
New FDA guidance pushes durability to the forefront as industry giants deepen their metabolic bets

INNOVATION
3 Dec 2025
Firms explore AI to speed discovery as analysts note opportunity, uncertainty and a fluid competitive landscape
By submitting, you agree to receive email communications from the event organizers, including upcoming promotions and discounted tickets, news, and access to related events.